CS
PBM icon

Clear Street’s Psyence Biomedical PBM Stock Holding History

Clear Street’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$6K – 758
2024
Q2 		$6K Buy
+5
New +$15K ﹤0.01% 471

Other funds holding PBM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Clear Street's PBM Position: Q3 2024 in Review

Clear Street sold out of Psyence Biomedical (PBM) in Q3 2024, closing a stake of 5 shares — an estimated $6K sold.

Clear Street first reported a position in PBM in Q2 2024 and held it in 1 quarter. The position peaked at $6K in Q2 2024. 11 funds tracked by Wall St. Rank hold PBM as of Q3 2024.

  • Clear Street reported no remaining Psyence Biomedical position as of Q3 2024 after selling out during the quarter.
  • Clear Street sold 5 Psyence Biomedical shares in Q3 2024, an estimated $6K.
  • Clear Street first reported a position in Psyence Biomedical in Q2 2024 and held it in 1 quarter.
  • Clear Street's Psyence Biomedical position peaked at $6K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2024.

Based on Clear Street's 13F filing for Q3 2024, filed 14 Nov 2024.